News

Class Action Opportunity for ZoomInfo Investors Facing Losses

Class Action Opportunity for ZoomInfo Investors Facing Losses

Investors' Opportunity with ZoomInfo Technologies, Inc.

Attention all investors! A class action lawsuit has been filed against ZoomInfo Technologies, Inc., commonly known as ZoomInfo. If you own shares in ZoomInfo and have faced serious financial losses, now’s your chance to take a stand. This lawsuit brings to light important allegations that could affect many investors who purchased ZoomInfo securities during a specific class period.

Understanding the Class Action Lawsuit

This legal proceeding aims to address concerns on behalf of anyone who bought or acquired ZoomInfo securities between certain dates. If that sounds like you, it’s vital to know your rights. The law firm Bronstein, Gewirtz & Grossman, LLC, is representing affected investors and working towards recovering damages for alleged violations of federal securities laws.

Key Issues Raised in the Case

The lawsuit claims that the company made misleading statements and failed to reveal critical information during the class period. Here are the main allegations:

  • ZoomInfo's financial results were artificially inflated by the COVID-19 pandemic, leading to a spike in demand that might not last.
  • Reports indicate that many current customers have been reducing or halting their use of ZoomInfo's services, which could lead to long-term revenue declines.
  • Allegations have arisen that ZoomInfo used coercive tactics to keep customer contracts intact, straining relationships and tarnishing the company’s image.
  • Such practices have created an exaggerated view of ZoomInfo's operational health, hiding concerning trends regarding customer retention and revenue sustainability.

Next Steps for Interested Investors

A class action has already been submitted. If you’ve incurred losses related to your ZoomInfo investment, there’s a route to potentially recover your money. Interested individuals should take some time to review the Complaint filed in this case. For more details, visit the firm's website or reach out to the attorneys handling the case directly.

Legal Representation Without Upfront Costs

One major benefit of working with Bronstein, Gewirtz & Grossman is that they operate on a contingency fee basis. This means you won't pay anything unless the attorneys successfully recover funds for you. They will only seek reimbursement for expenses and a portion of the recovery if they win the case.

Why Choose Bronstein, Gewirtz & Grossman, LLC?

Bronstein, Gewirtz & Grossman enjoys a solid reputation for their work representing investors in securities fraud class actions. Their record speaks volumes—they have helped recover hundreds of millions of dollars for investors across the country. With an experienced legal team, they are committed to upholding investors' rights.

Contact Information

If you think you qualify to join this class action lawsuit or need more information, feel free to contact Peretz Bronstein or Nathan Miller at Bronstein, Gewirtz & Grossman. You can reach them at 332-239-2660 or by email at info@bgandg.com.

Frequently Asked Questions

What is a class action lawsuit?

A class action lawsuit allows a group of individuals with similar claims to file a case collectively, which can streamline the process and give individual investors access to legal recourse.

Who can join the class action against ZoomInfo?

Investors who purchased or acquired ZoomInfo securities within the specified dates during the class period may be eligible to participate in the lawsuit.

What are the costs involved in joining this lawsuit?

There are no upfront costs to you. The law firm works on a contingency fee basis, meaning they only collect fees if the case is successful.

How can I find out more information about the class action?

You can visit the firm’s website for detailed information, or directly contact their representatives for specific questions.

What happens next in the legal process?

The law firm will keep all participants updated about the lawsuit's progress and any significant developments in the court proceedings.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Intus Bio Secures $2.7M for Colorectal Cancer Test

Updated Category News Views 4

Pioneering Efforts in Early-Onset Colorectal Cancer Detection The battlefield of colorectal cancer prevention just got a serious upgrade with Intus Bio grabbing a $2.7 million award. This ain't just pocket change—it's a shot at rewriting the script on how we approach early-onset colorectal cancer, the pesky number one cancer gnawing at the under-50 crowd. Partnering...

Continue Reading
USFCR Wins 2026 Award for Federal Contracting Services

Updated Category News Views 7

Award-Winning Federal Contracting Strategies News from Clearwater, Florida: US Federal Contractor Registration (USFCR) just bagged the 2026 nod from Gov Business Review as the Federal Contracting Services of the Year. Now that's a feather in the cap worth talking about. This isn't some hallway compliment, folks. It's a signal that they've nailed how to get businesses...

Continue Reading
DCM Services Teams with AKUVO to Boost Estate Recoveries

Updated Category News Views 3

Revolutionizing Estate Recovery Practices Here's the scoop: DCM Services (DCMS), that big shot in estate account resolution, is hooking up with AKUVO to shake up how credit unions handle estate recoveries. This alliance is a clear nod to modernizing a process stuck in the past. Let’s face it, handling decedent and probate accounts is no cakewalk, and traditional methods...

Continue Reading
Modeling and Mental Health Join Forces for Wellness

Updated Category News Views 2

A Fresh Alliance for Mental Wellness in Modeling Alright, let's shine a spotlight on a significant step in the modeling industry, a place typically less vocal about mental health. In a move that feels long overdue, Brain-Body Therapy and Mother Model Management have joined forces, marking the beginning of a collaborative effort to propel mental wellness to the forefront...

Continue Reading
Flex Dental Solutions Adds BNPL, Surcharging to FlexPayments

Updated Category News Views 7

Diving into Dental Finances: A New Moneymaker? It's about time someone shook up the dental payment scene, and Flex Dental Solutions seems to be the one doing it. They rolled out some intriguing new features for their FlexPayments platform aimed squarely at dental practices using Open Dental. What we're seeing here is their attempt to bridge a couple of financial headaches...

Continue Reading
CrossCountry Mortgage Boosts Loan Limits, Flexibility for 2027

Updated Category News Views 28

Trailblazing in the Mortgage Game Well, what do we have here? CrossCountry Mortgage, the big cheese of retail mortgage lenders, is cranking up their conforming loan limits to a hefty $845,000. They're jumping the gun on the Federal Housing Finance Agency's official 2027 announcement. It's a classic move—proactive, bold, and a bit of a gamble, if you ask me. They’re...

Continue Reading
Veteran Marketer Joins The Wisory's Advisory Board

Updated Category News Views 5

Tyrrell Schmidt Joins The Wisory's Board Out of the blue, The Wisory has snatched Tyrrell Schmidt right off the retirement bench. This doesn't seem like just another board seating; it smells like a calculated power play. Schmidt, fresh from her heavyweight stint as Global CMO at TD Bank, adds a spicy dose of marketing prowess to The Wisory's already loaded Advisory Board....

Continue Reading
Melissa Rivers Brings Her Wit Back to Emmys Carpet

Updated Category News Views 5

They say you can never go home again, but don't tell that to Melissa Rivers. Rolling the dice on nostalgia and kicking off a new chapter, she's waltzing back to the Emmys red carpet for the first time in nearly 20 years. Alright, what's in it for investors? Not much—unless you're looking to invest in nostalgia. But there's something here about legacy, reinvention, and...

Continue Reading
Crystal Risotti: Leading IT Compliance in Healthcare

Updated Category News Views 6

A Journey Marked by Dedication and Expertise In the demanding world of healthcare technology, where regulations can make or break a company, Crystal Risotti has carved out a space for herself as a leader. Over the last 30 years, she's developed a reputation for blending regulatory expertise with practical business strategies. Her recognition as a Pinnacle Professional of...

Continue Reading
Seismic Pharma Kicks Off Phase 3 Trial for Istaroxime

Updated Category News Views 4

Seismic Sets the Stage for a Medical Milestone From the heart of biotech in Durham, North Carolina, seismic waves ripple through the medical community as Seismic Pharmaceuticals embarks on a high-stakes adventure. It's official: they've enrolled their very first patient in the global Phase 3 trial of istaroxime, targeting the grim specter known as cardiogenic shock. You...

Continue Reading

Top 5 Most Recently Viewed Articles

BioSig Technologies Updates on Merger and Share Issuance Plans

Updated Category News Views 169

BioSig Technologies Provides Merger Update LOS ANGELES and VANCOUVER, British Columbia — BioSig Technologies, Inc. (NASDAQ: BSGM), recently provided a significant update regarding its merger with Streamex Exchange Corporation. The recent developments aim to clarify the status of the merger and ensure all shareholders are informed. Details of the Merger Finalization The...

Continue Reading
Al Hurra Cuts Jobs and Merges Iraq Channel Amid Budget Cuts

Updated Category News Views 136

Al Hurra Faces Major Workforce Reductions The parent organization of the Arabic language broadcaster Al Hurra has announced significant layoffs, resulting in the elimination of 160 positions. This decision comes in the wake of a 20% budget cut mandated by the U.S. Congress, as revealed by the company’s CEO in a message to staff. Understanding the Budget Cuts Dr. Jeffrey...

Continue Reading
Strategies for Success in Hinge Research Institute's 2025 Study

Updated Category News Views 627

Innovative Strategies Highlighted in Hinge Research's 2025 Study Hinge Research Institute stands at the forefront of research on professional services growth. With its recent 10th Annual High Growth Study, the institute has delivered crucial insights into how successful firms thrive in today’s rapidly evolving market. The study not only illustrates the growth potential...

Continue Reading
Psyence Biomed Celebrates Milestones in Psilocybin Development

Updated Category News Views 125

Recent Developments in Psyence Biomed's Journey In a significant update shared by Psyence Biomedical Ltd. (Nasdaq: PBM), the company has showcased its achievements, reflecting a positive trajectory in the realm of psychedelic-based therapeutics. Highlights from the update included the impressive valuation of their stake in PsyLabs, strong clinical trial progress, and a...

Continue Reading
Rugby Resources Limited Expands Private Placement Offerings

Updated Category News Views 146

Rugby Resources Limited Expands Private Placement Opportunities Rugby Resources Ltd. (TSX-V: RUG) has announced an important development regarding its private placement offering. Responding to high subscriber demand, the company's board has authorized an increase in the number of available units, raising the offering from 60 million units to an impressive 81.84 million...

Continue Reading